Literature DB >> 14715748

Increased sensitivity of mannanemia detection tests by joint detection of alpha- and beta-linked oligomannosides during experimental and human systemic candidiasis.

Boualem Sendid1, Thierry Jouault, Richard Coudriau, Daniel Camus, Frank Odds, Marc Tabouret, Daniel Poulain.   

Abstract

An enzyme immunoassay (EIA)-the commercially available Platelia Candida antigen test-developed for the diagnosis of systemic candidiasis is based on the detection of alpha-linked oligomannose residues (alpha-Man) released from Candida cells into the serum. This test has good specificity but has to be repeated frequently because of the rapid clearance of detectable mannanemia. We have developed a second EIA based on detection of beta-linked oligomannoses (beta-Man), since beta-Man are linked to different Candida molecules and interact differently with the host immune system and endogenous lectins and should therefore present different kinetics of serum clearance. In a guinea pig model of Candida albicans systemic infection, the relative amounts of detectable alpha- and beta-Man differed considerably according to the virulence of the strain, the infecting dose, and the time after challenge that serum samples were drawn. Detection of alpha-Man was more sensitive per serum sample than that of beta-Man, and the sensitivity for the combination reached 90%. The same tests were applied to 90 sera from 26 patients selected retrospectively for having been infected with the most-pathogenic Candida species: C. albicans (19), C. tropicalis (4), and C. glabrata (3). A total of 22 patients had positive antigenemia, 4 had alpha-mannanemia, 4 had beta-mannanemia, and 14 showed the presence of both. For the patients showing the presence of both forms of mannanemia, the use of both tests enhanced the duration of the detection of mannanemia. Mannanemia was correlated with early clinical symptoms and isolation of Candida in culture, which occurred in 55% of the patients at an average of 4.7 days after the first positive mannanemia test result. A combination of the two tests had a cumulated specificity of 95%, and positive and negative predictive values were 79 and 97%, respectively. These findings provide evidence for different kinetics of beta- and alpha-Man circulation during experimental and human candidiasis and suggest the joint detection of both types of epitopes as a rational approach contributing to increases in the sensitivity and earliness of diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715748      PMCID: PMC321671          DOI: 10.1128/JCM.42.1.164-171.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

2.  Differential humoral response against alpha- and beta-linked mannose residues associated with tissue invasion by Candida albicans.

Authors:  T Jouault; C Delaunoy; B Sendid; F Ajana; D Poulain
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Evidence for different mannosylation processes involved in the association of beta-1,2-linked oligomannosidic epitopes in Candida albicans mannan and phospholipomannan.

Authors:  P A Trinel; C Cantelli; A Bernigaud; T Jouault; D Poulain
Journal:  Microbiology       Date:  1996-08       Impact factor: 2.777

4.  Assessment of detection of Candida mannoproteinemia as a method to differentiate central venous catheter-related candidemia from invasive disease.

Authors:  C Girmenia; P Martino; F De Bernardis; A Cassone
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Nosocomial candidemia: risk factors and attributable mortality.

Authors:  R P Wenzel
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

6.  Enolase antigen, mannan antigen, Cand-Tec antigen, and beta-glucan in patients with candidemia.

Authors:  K Mitsutake; T Miyazaki; T Tashiro; Y Yamamoto; H Kakeya; T Otsubo; S Kawamura; M A Hossain; T Noda; Y Hirakata; S Kohno
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

7.  Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species.

Authors:  C Cantelli; P A Trinel; A Bernigaud; T Jouault; L Polonelli; D Poulain
Journal:  Microbiology (Reading)       Date:  1995-10       Impact factor: 2.777

8.  Optimization of the covalent conjugating procedure (NaIO4) of horseradish peroxidase to antibodies for use in enzyme-linked immunosorbent assay.

Authors:  V C Tsang; R M Greene; J B Pilcher
Journal:  J Immunoassay       Date:  1995-11

9.  Retrospective evaluation of two latex agglutination tests for detection of circulating antigens during invasive candidosis.

Authors:  P Herent; D Stynen; F Hernando; J Fruit; D Poulain
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes.

Authors:  T Obayashi; M Yoshida; T Mori; H Goto; A Yasuoka; H Iwasaki; H Teshima; S Kohno; A Horiuchi; A Ito
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

View more
  11 in total

1.  Effect of antifungal therapy timing on mortality in cancer patients with candidemia.

Authors:  Ying Taur; Nina Cohen; Sarah Dubnow; Alla Paskovaty; Susan K Seo
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

2.  A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts.

Authors:  Matteo Bassetti; Monia Marchetti; Arunaloke Chakrabarti; Sergio Colizza; Jose Garnacho-Montero; Daniel H Kett; Patricia Munoz; Francesco Cristini; Anastasia Andoniadou; Pierluigi Viale; Giorgio Della Rocca; Emmanuel Roilides; Gabriele Sganga; Thomas J Walsh; Carlo Tascini; Mario Tumbarello; Francesco Menichetti; Elda Righi; Christian Eckmann; Claudio Viscoli; Andrew F Shorr; Olivier Leroy; George Petrikos; Francesco Giuseppe De Rosa
Journal:  Intensive Care Med       Date:  2013-10-09       Impact factor: 17.440

Review 3.  Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis.

Authors:  Benoît P Guery; Maiken C Arendrup; Georg Auzinger; Elie Azoulay; Márcio Borges Sá; Elizabeth M Johnson; Eckhard Müller; Christian Putensen; Coleman Rotstein; Gabriele Sganga; Mario Venditti; Rafael Zaragoza Crespo; Bart Jan Kullberg
Journal:  Intensive Care Med       Date:  2008-10-30       Impact factor: 17.440

4.  Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan.

Authors:  B Sendid; N Dotan; S Nseir; C Savaux; P Vandewalle; A Standaert; F Zerimech; B P Guery; A Dukler; J F Colombel; D Poulain
Journal:  Clin Vaccine Immunol       Date:  2008-10-29

5.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

6.  Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes.

Authors:  Chantal Fradin; Marie Christine Slomianny; Céline Mille; Annick Masset; Raymond Robert; Boualem Sendid; Joachim F Ernst; Jean Claude Michalski; Daniel Poulain
Journal:  Infect Immun       Date:  2008-07-21       Impact factor: 3.441

7.  Immunoglobulin G responses to a panel of Candida albicans antigens as accurate and early markers for the presence of systemic candidiasis.

Authors:  Cornelius J Clancy; Minh-Ly Nguyen; Shaoji Cheng; Hong Huang; Guixiang Fan; Reia A Jaber; John R Wingard; Christina Cline; M Hong Nguyen
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

8.  Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David Andes; Daniel K Benjamin; Thierry F Calandra; John E Edwards; Scott G Filler; John F Fisher; Bart-Jan Kullberg; Luis Ostrosky-Zeichner; Annette C Reboli; John H Rex; Thomas J Walsh; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2009-03-01       Impact factor: 9.079

9.  Diagnostic performance of 1→3-β-d-glucan in neonatal and pediatric patients with Candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Grazia Lovero; Osvalda De Giglio; Osvaldo Montagna; Nicola Laforgia; Nicola Santoro; Giuseppina Caggiano
Journal:  Int J Mol Sci       Date:  2011-09-14       Impact factor: 5.923

Review 10.  The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.

Authors:  Malgorzata Mikulska; Thierry Calandra; Maurizio Sanguinetti; Daniel Poulain; Claudio Viscoli
Journal:  Crit Care       Date:  2010-12-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.